These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 14737967

  • 1. [Dendritic cells and their applications in cancer immunotherapy--achievements and future prospects].
    Rossowska J, Pajtasz-Piasecka E.
    Postepy Hig Med Dosw; 2003; 57(5):501-18. PubMed ID: 14737967
    [Abstract] [Full Text] [Related]

  • 2. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D, Moyana T, Xiang J.
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [Abstract] [Full Text] [Related]

  • 3. The use of dendritic cells for cancer vaccination.
    Esche C, Shurin MR, Lotze MT.
    Curr Opin Mol Ther; 1999 Feb; 1(1):72-81. PubMed ID: 11249687
    [Abstract] [Full Text] [Related]

  • 4. Dendritic cell-based immunotherapy.
    Osada T, Clay TM, Woo CY, Morse MA, Lyerly HK.
    Int Rev Immunol; 2006 Feb; 25(5-6):377-413. PubMed ID: 17169781
    [Abstract] [Full Text] [Related]

  • 5. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T, Kamigaki T, Nakamura T, Imanishi T, Hayashi S, Kawasaki K, Takase S, Ajiki T, Kuroda Y.
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [Abstract] [Full Text] [Related]

  • 6. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dendritic cells and their role in cancer immunotherapy.
    Jalili A.
    Iran J Immunol; 2007 Sep; 4(3):127-44. PubMed ID: 17767012
    [Abstract] [Full Text] [Related]

  • 11. [Unveiling antigens in a non-immunogenic spontaneous murine tumor using a dendritic cell based vaccine].
    Reffo VL, Chiarella P, Bruzzo J, Bustuoabad OD, Ruggiero RA.
    Medicina (B Aires); 2008 Sep; 68(4):301-4. PubMed ID: 18786887
    [Abstract] [Full Text] [Related]

  • 12. Optimizing dendritic cell-based immunotherapy for cancer.
    Zhong H, Shurin MR, Han B.
    Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749
    [Abstract] [Full Text] [Related]

  • 13. Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma.
    Sun K, Wang L, Zhang Y.
    Cell Mol Immunol; 2006 Jun; 3(3):197-203. PubMed ID: 16893500
    [Abstract] [Full Text] [Related]

  • 14. Current issues in dendritic cell cancer immunotherapy.
    López JA, Hart DN.
    Curr Opin Mol Ther; 2002 Feb; 4(1):54-63. PubMed ID: 11885565
    [Abstract] [Full Text] [Related]

  • 15. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
    Bodey B, Siegel SE, Kaiser HE.
    In Vivo; 2004 Feb; 18(1):81-100. PubMed ID: 15011756
    [Abstract] [Full Text] [Related]

  • 16. Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.
    Suzuki T, Fukuhara T, Tanaka M, Nakamura A, Akiyama K, Sakakibara T, Koinuma D, Kikuchi T, Tazawa R, Maemondo M, Hagiwara K, Saijo Y, Nukiwa T.
    Clin Cancer Res; 2005 Jan 01; 11(1):58-66. PubMed ID: 15671528
    [Abstract] [Full Text] [Related]

  • 17. Cell fusion: from hybridoma to dendritic cell-based vaccine.
    Gong J, Koido S, Calderwood SK.
    Expert Rev Vaccines; 2008 Sep 01; 7(7):1055-68. PubMed ID: 18767954
    [Abstract] [Full Text] [Related]

  • 18. Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy.
    Schreurs MW, Eggert AA, Punt CJ, Figdor CG, Adema GJ.
    Crit Rev Oncog; 2000 Sep 01; 11(1):1-17. PubMed ID: 10795625
    [Abstract] [Full Text] [Related]

  • 19. Dendritic cell-based cancer immunotherapies.
    Fujii S, Takayama T, Asakura M, Aki K, Fujimoto K, Shimizu K.
    Arch Immunol Ther Exp (Warsz); 2009 Sep 01; 57(3):189-98. PubMed ID: 19479202
    [Abstract] [Full Text] [Related]

  • 20. The use of dendritic cells in cancer immunotherapy.
    Nencioni A, Grünebach F, Schmidt SM, Müller MR, Boy D, Patrone F, Ballestrero A, Brossart P.
    Crit Rev Oncol Hematol; 2008 Mar 01; 65(3):191-9. PubMed ID: 18055210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.